Cargando…

Modifications in Bone Matrix of Estrogen-Deficient Rats Treated with Intermittent PTH

Bone matrix dictates strength, elasticity, and stiffness to the bone. Intermittent parathyroid hormone (iPTH), a bone-forming treatment, is widely used as a therapy for osteoporosis. We investigate whether low doses of intermittent PTH (1-34) change the profile of organic components in the bone matr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacheco-Costa, Rafael, Campos, Jenifer Freitas, Katchburian, Eduardo, de Medeiros, Valquíria Pereira, Nader, Helena Bonciani, Nonaka, Keico Okino, Plotkin, Lilian Irene, Reginato, Rejane Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324816/ https://www.ncbi.nlm.nih.gov/pubmed/25695082 http://dx.doi.org/10.1155/2015/454162

Ejemplares similares

Osteocytic connexin 43 is not required for the increase in bone mass induced by intermittent PTH administration in male mice
por: Pacheco-Costa, R., et al.
Publicado: (2016)

Changes in human intervertebral disc biochemical composition and bony end plates between middle and old age
por: Martins, Delio Eulalio, et al.
Publicado: (2018)

Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
por: O'Brien, Charles A., et al.
Publicado: (2008)

Low Bone Turnover and Low BMD in Down Syndrome: Effect of Intermittent PTH Treatment
por: Fowler, Tristan W., et al.
Publicado: (2012)

Evaluating Osteogenic Differentiation of Osteoblastic Precursors Upon Intermittent Administration of PTH/IGFBP7
por: Xia, Han, et al.
Publicado: (2022)

PTH Receptor Signaling in Osteocytes Governs Periosteal Bone Formation and Intracortical Remodeling
por: Rhee, Yumie, et al.
Publicado: (2011)

Exercise and Omentin: Their Role in the Crosstalk Between Muscle and Adipose Tissues in Type 2 Diabetes Mellitus Rat Models
por: de Castro, Cynthia Aparecida, et al.
Publicado: (2019)

Intermittent PTH administration improves alveolar bone formation in type 1 diabetic rats with periodontitis
por: Kim, Ji-Hye, et al.
Publicado: (2018)

Intermittent parathyroid hormone (PTH) promotes cementogenesis and alleviates the catabolic effects of mechanical strain in cementoblasts
por: Li, Yuyu, et al.
Publicado: (2017)

The role of intermittent PTH administration in conjunction with allogenic stem cell treatment to stimulate fracture healing
por: Osagie-Clouard, Liza, et al.
Publicado: (2021)

Changes over time in callus formation caused by intermittently administering PTH in rabbit distraction osteogenesis models
por: Ohata, Tetsuya, et al.
Publicado: (2015)

Effects of pre-extraction intermittent PTH administration on extraction socket healing in bisphosphonate administered ovariectomized rats
por: Kim, Jae-Young, et al.
Publicado: (2021)

Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long‐Acting PTH Analog (LA‐PTH)
por: Noda, Hiroshi, et al.
Publicado: (2020)

NACA and LRP6 Are Part of a Common Genetic Pathway Necessary for Full Anabolic Response to Intermittent PTH
por: St-Arnaud, René, et al.
Publicado: (2022)

Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatment
por: Baranowsky, Anke, et al.
Publicado: (2022)

Resveratrol Treatment Normalizes the Endothelial Function and Blood Pressure in Ovariectomized Rats
por: Fabricio, Victor, et al.
Publicado: (2017)

Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients
por: Zuo, Jiao, et al.
Publicado: (2023)

COMPARATIVE STUDY OF THE EFFECTS OF LOW-LEVEL LASER AND LOW-INTENSITY ULTRASOUND ASSOCIATED WITH BIOSILICATE(®) ON THE PROCESS OF BONE REPAIR IN THE RAT TIBIA
por: Oliveira, Poliani de, et al.
Publicado: (2015)

Disruption of PTH Receptor 1 in T Cells Protects against PTH-Induced Bone Loss
por: Tawfeek, Hesham, et al.
Publicado: (2010)

The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

OR07-01 Identification of the First Case of Acquired Autoimmune Parathyroid Hormone (PTH) Resistance Due to PTH1 Receptor (PTH1R) Autoantibodies
por: Mandl, Adel, et al.
Publicado: (2020)

Resistance Training Modulates the Matrix Metalloproteinase-2 Activity in Different Trabecular Bones in Aged Rats
por: de Sousa Neto, Ivo Vieira, et al.
Publicado: (2021)

Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range
por: Medas, Fabio, et al.
Publicado: (2019)

Determinants of Low Bone Turnover in Type 2 Diabetes-the Role of PTH
por: Vavanikunnel, Janina, et al.
Publicado: (2022)

Hypocalcemia after thyroidectomy: iPTH levels and iPTH decline are predictive? Retrospective cohort study()
por: Cannizzaro, Matteo Angelo, et al.
Publicado: (2018)

Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance
por: Demaret, Tanguy, et al.
Publicado: (2022)

Endogenous PTH Deficiency Impairs Fracture Healing and Impedes the Fracture-Healing Efficacy of Exogenous PTH(1-34)
por: Ren, Yongxin, et al.
Publicado: (2011)

Decrease in the expression of the type 1 PTH/PTHrP receptor (PTH1R) on chondrocytes in animals with osteoarthritis
por: Becher, Christoph, et al.
Publicado: (2010)

Decreased expression of calcium-sensing receptor and parafibromin in secondary hyperparathyroidism with an abnormal whole PTH/intact PTH ratio
por: Yamada, Shunsuke, et al.
Publicado: (2013)

Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH
por: Kuragano, Takahiro, et al.
Publicado: (2013)

Prolonged Treatments With Antiresorptive Agents and PTH Have Different Effects on Bone Strength and the Degree of Mineralization in Old Estrogen-Deficient Osteoporotic Rats
por: Cheng, Zhiqiang, et al.
Publicado: (2009)

Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts
por: Vicente, Carolina Meloni, et al.
Publicado: (2013)

Neonatal transient pseudohypoparathyroidism: could it be included among inactivating parathyroid hormone (PTH)/PTH-related protein signalling disorders?
por: De Rose, Domenico Umberto, et al.
Publicado: (2019)

Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients
por: Einbinder, Yael, et al.
Publicado: (2017)

Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure
por: Kritmetapak, Kittrawee, et al.
Publicado: (2021)

Recombinant PTH associated with hypercalcaemia and renal failure
por: Ayasreh, Nadia, et al.
Publicado: (2013)

PTH Reloaded: A New Evolutionary Perspective
por: Suarez-Bregua, Paula, et al.
Publicado: (2017)

Low PTH Levels in Adolescents With Anorexia Nervosa
por: Lenherr-Taube, Nina, et al.
Publicado: (2020)

Role of Gut Microbiota in the Skeletal Response to PTH
por: Pacifici, Roberto
Publicado: (2020)

Precise druggability of the PTH type 1 receptor
por: Sutkeviciute, Ieva, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g3heelb05dbm23avhhdghdi7rb